- Home
- ABEO vs PCYO Comparison
ABEO vs PCYO Comparison
Compare ABEO & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- PCYO
- Stock Information
- Founded
- ABEO 1974
- PCYO 1976
- Country
- ABEO United States
- PCYO United States
- Employees
- ABEO N/A
- PCYO N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- PCYO Water Supply
- Sector
- ABEO Health Care
- PCYO Utilities
- Exchange
- ABEO Nasdaq
- PCYO Nasdaq
- Market Cap
- ABEO 256.9M
- PCYO 248.0M
- IPO Year
- ABEO 1980
- PCYO N/A
- Fundamental
- Price
- ABEO $5.76
- PCYO $10.74
- Analyst Decision
- ABEO Strong Buy
- PCYO
- Analyst Count
- ABEO 6
- PCYO 0
- Target Price
- ABEO $18.00
- PCYO N/A
- AVG Volume (30 Days)
- ABEO 1.1M
- PCYO 39.8K
- Earning Date
- ABEO 08-11-2025
- PCYO 07-09-2025
- Dividend Yield
- ABEO N/A
- PCYO N/A
- EPS Growth
- ABEO N/A
- PCYO 118.08
- EPS
- ABEO N/A
- PCYO 0.59
- Revenue
- ABEO N/A
- PCYO $29,911,000.00
- Revenue This Year
- ABEO N/A
- PCYO N/A
- Revenue Next Year
- ABEO $323.51
- PCYO N/A
- P/E Ratio
- ABEO N/A
- PCYO $18.16
- Revenue Growth
- ABEO N/A
- PCYO 58.85
- 52 Week Low
- ABEO $3.93
- PCYO $9.10
- 52 Week High
- ABEO $7.32
- PCYO $14.63
- Technical
- Relative Strength Index (RSI)
- ABEO 45.63
- PCYO 56.99
- Support Level
- ABEO $5.66
- PCYO $10.16
- Resistance Level
- ABEO $6.24
- PCYO $10.50
- Average True Range (ATR)
- ABEO 0.29
- PCYO 0.27
- MACD
- ABEO -0.07
- PCYO 0.03
- Stochastic Oscillator
- ABEO 20.34
- PCYO 85.19
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.